» Authors » O Johansen

O Johansen

Explore the profile of O Johansen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 68
Citations 248
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Abdelnoor M, Vengen O, Johansen O, Sandven I, Abdelnoor A
Clin Epidemiol . 2016 Jun; 8:151-63. PMID: 27330329
Objective: We aimed to summarize the pooled frequency of mediastinitis following open-heart surgery caused by Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA), and Gram-negative bacteria. Design: This study was a...
2.
Steinnes E, Johansen O, Royset O, Odegard M
Environ Monit Assess . 2013 Nov; 25(2):87-97. PMID: 24225658
Mosses are used as biomonitors on a regular basis to study trends in the atmospheric deposition of trace elements in Norway. In this paper the analytical scheme used so far,...
3.
Meknas K, Johansen O, Steigen S, Olsen R, Jorgensen L, Kartus J
Scand J Med Sci Sports . 2011 Mar; 22(5):627-34. PMID: 21410541
Ten patients, age 60 (48-75 years), with osteoarthritis (OA) of the hip and 10 patients, age 82.5 (60-90 years), with fracture of the collum femoris (FCF; minimum Garden stage III)...
4.
Bethune C, Seierstad S, Seljeflot I, Johansen O, Arnesen H, Meltzer H, et al.
Eur J Clin Invest . 2006 Mar; 36(3):193-201. PMID: 16506965
Background: In a previous study, a group of coronary heart disease (CHD) patients exhibited positive cardioprotective effects of fatty acids derived from a diet of farmed Atlantic salmon fed fish...
5.
Seierstad S, Seljeflot I, Johansen O, Hansen R, Haugen M, Rosenlund G, et al.
Eur J Clin Invest . 2005 Jan; 35(1):52-9. PMID: 15638820
Background: Cardioprotective effects of omega-3 polyunsaturated fatty acids (n-3 PUFAs) of marine origin are well recognized. Because of the shortness of marine resources vegetable oils are increasingly used in fish...
6.
Johansen O, Brekke M, Seljeflot I, Semb A, Arnesen H
Scand Cardiovasc J . 2004 Nov; 38(4):211-5. PMID: 15553931
Objectives: Restenosis occurs in 40-50% of patients treated with percutaneous transluminal coronary angioplasty (PTCA). Some data indicate that platelet derived growth factor (PDGF) plays a pathogenetic role. The aims of...
7.
Johansen O, Winge J, Reikeras O, Jensen T, Knutsen G
Scand J Clin Lab Invest . 2004 Oct; 64(7):635-39. PMID: 15513320
Plasma beta-endorphin/beta-lipotropin concentration was assessed soon after a fracture. Blood samples from 14 patients with radius fractures were obtained from both arms soon after admission to the hospital (mean 245...
8.
Figenschau Y, Knutsen G, Shahazeydi S, Johansen O, Sveinbjornsson B
Biochem Biophys Res Commun . 2001 Sep; 287(1):190-7. PMID: 11549273
The effects of leptin hormone are mediated by interactions with several physiological regulatory systems and the cytokine network, and by targeting cells directly. The leptin receptor is a member of...
9.
Johansen O, Abdelnoor M, Brekke M, Seljeflot I, Hostmark A, Arnesen H
Scand Cardiovasc J . 2001 Jun; 35(2):86-91. PMID: 11405502
Objective: The major concern about percutaneous transluminal coronary angioplasty (PTCA) is the high incidence of restenosis. Methods: Demographic, clinical and biochemical data were recorded 2 weeks prior to PTCA in...
10.
Hjalmarsen A, Viitanen M, Jenssen T, Jorde R, Johansen O
Scand J Clin Lab Invest . 2000 Dec; 60(6):501-6. PMID: 11129066
The present study is concerned with plasma beta-endorphin and glucose tolerance in patients with chronic obstructive pulmonary disease (COPD). Plasma beta-endorphin, glucagon and insulin concentrations were measured during an oral...